Alerts will be sent to your verified email
Verify EmailSMSPHARMA
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
SMS Pharmaceuticals Ltd is a leading Indian pharmaceutical manufacturer with state-of-the-art facilities meeting international standards. The company received export house status in 1997-98 and serves a growing global and local customer base.
SMS Pharmaceuticals major competitors are IOL Chem & Pharma, Solara Active Pharma, Bajaj Healthcare, Hester Biosciences, Themis Medicare, Aarti Drugs, Morepen Laboratories.
Market Cap of SMS Pharmaceuticals is ₹2,124 Crs.
While the median market cap of its peers are ₹1,887 Crs.
SMS Pharmaceuticals seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | ||||||||||||||
Investor Presentation | Mar Jun Sep Dec | Mar Jun Sep Dec | Feb Mar Jun Aug Sep Dec | Sep Dec | ||||||||||||||
Conference Call | Mar Jun Sep | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep | ||||||||||||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|